Nihon Kohden (OTCMKTS:NHNKY) Sees Strong Trading Volume - Time to Buy?

Key Points

• UBS upgraded Nihon Kohden from a "hold" to a "strong-buy" on Jan. 19, and the stock's average analyst rating is listed as Strong Buy.
• Shares last traded at $9.66 (up about 2.1%) with mid-day volume of 18,919 — down 31% from the prior session — and the stock is trading below its 50-day ($10.29) and 200-day ($10.93) moving averages.
• Recent quarterly results showed $0.16 EPS and $362.86M in revenue; the company has a $1.68B market cap, a P/E of 19.22, ROE of 7.25% and a net margin of 5.32%.

Nihon Kohden Corporation (OTCMKTS:NHNKY - Get Free Report) shares saw strong trading volume on Monday . 18,919 shares were traded during mid-day trading, a decline of 31% from the previous session's volume of 27,606 shares.The stock last traded at $9.66 and had previously closed at $9.6050.

Analysts Set New Price Targets

Separately, UBS Group raised Nihon Kohden from a "hold" rating to a "strong-buy" rating in a research report on Monday, January 19th. One research analyst has rated the stock with a Strong Buy rating, According to data from MarketBeat.com, the stock has an average rating of "Strong Buy".

Nihon Kohden Trading Up 2.1%

The firm has a market cap of $1.68 billion, a PE ratio of 19.22 and a beta of 0.46. The business has a fifty day moving average price of $10.29 and a 200 day moving average price of $10.93.

Nihon Kohden (OTCMKTS:NHNKY - Get Free Report) last released its quarterly earnings data on Thursday, February 5th. The company reported $0.16 EPS for the quarter. Nihon Kohden had a return on equity of 7.25% and a net margin of 5.32%.The business had revenue of $362.86 million for the quarter.

Nihon Kohden Company Profile

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan's earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company's core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.